HOME
About Us
  • About
  • Team
  • Our Legacy
Contact

nano group, PBC

nano group, PBCnano group, PBCnano group, PBC
HOME
About Us
  • About
  • Team
  • Our Legacy
Contact
More
  • HOME
  • About Us
    • About
    • Team
    • Our Legacy
  • Contact

nano group, PBC

nano group, PBCnano group, PBCnano group, PBC
  • HOME
  • About Us
    • About
    • Team
    • Our Legacy
  • Contact

dr. jason dictenberg, phd

Portrait of a man in glasses and a suit jacket.

Chief Medication Officer, Co-Founder

 

 Albert Einstein Scholar & Inter. Society of Developmental Neuroscience Awards - ASD & RNA Biology, PEAK Anxiety    

A  neuroscientist and molecular biology researcher known for his work in neuronal RNA transport, synaptic plasticity, Fragile X Syndrome, autism-related pathways, and live-cell RNA imaging technologies. His research focuses on how messenger RNA (mRNA) moves within neurons and how these processes influence brain development, learning, memory, and neurological disease.

Alzheimer’s Drug, Disease & Neurological Research Contributions

  • Advisory Board Member associated with the Alzheimer's Drug Discovery Foundation, supporting innovation and advancement in neurological and Alzheimer’s-related research initiatives  
  • Research focused on neuronal communication, synaptic plasticity, RNA transport, and molecular mechanisms associated with neurodegenerative and neurological disorders 
  • Published and contributed to scientific work related to Fragile X Syndrome, autism pathways, neuronal signaling, and brain function that may have relevance to Alzheimer’s and neurodegenerative disease research 
  • Experience studying RNA-binding proteins, neuronal mRNA transport, and localized protein synthesis involved in brain health, learning, and memory 
  • Participated in neuroscience research involving live-cell RNA imaging, neural signaling pathways, and synaptic regulation technologies 
  • Involved in development of advanced AI and neuroscience-related technologies that combine emotional AI, biometrics, robotics, and cognitive engagement systems 
  • Helped develop emotionally intelligent robotic systems designed to support cognitive interaction, emotional wellness, anxiety reduction, autism support, depression support, and healthcare engagement for children and seniors 
  • Collaborated on healthcare-focused robotics and AI platforms intended to assist hospitals, caregivers, and pediatric healthcare environments 
  • Research and innovation efforts centered on improving neurological understanding, emotional engagement, patient communication, and future neurotechnology applications in healthcarPotential Relevance to AI & NeurotechnologyUnderstanding neuronal signaling and RNA transport mechanisms may contribute to future AI-assisted neurological diagnostics and therapeutics.

· Research on synaptic plasticity and neuronal communication can inform neurotechnology systems, brain-computer interfaces, and cognitive health applications.

· Live-cell imaging and RNA tracking methods may support future precision medicine and neurodegenerative disease monitoring technologies.

Prepared Summary Based on Published Research & Scientific Literature.

Back To Team

  • Contact

Nano Group, PBC, Inc.

Copyright © 2026 Nano Group,PBC - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept